ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO360

Using Binding Competitors of Albumin to Promote the Removal of Protein-Bound Uremic Toxins in Hemodialysis: Proof of Concept and Screening of Candidates

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis


  • Florens, Nans, Hospices Civils de Lyon, Lyon, France
  • Yi, Dan, CarMeN, INSERM u1060, INSA LYON, VILLEURBANNE, France
  • Soulère, Laurent, INSA LYON, Villeurbanne, France
  • Juillard, Laurent, Hospices Civils de Lyon, Lyon, France
  • Soulage, Christophe O., CarMeN, INSERM u1060, INSA LYON, VILLEURBANNE, France

Protein-bound uremic toxins (PBUT) remain a concerning burden as their removal in hemodialysis is limited by their strong interaction with albumin. Despite interesting animal data, the limitation of their intestinal production is disappointing. By enhancing their circulating free-fraction during hemodialysis, the use of binding competitors could be undertaken. The aim of this work was to evaluate the displacing capabilities of some selected solutes and to identify potential candidates for an in vivo development.


Displacement capacity of a fluorescent probe (dansylsarcosine) specific to Sudlow’s site II on albumin was tested in spectrofluorimetry. Displacement capacity was then expressed as a concentration displacer/albumin ratio. Short chain fatty acids were provided by Sigma-Aldrich. The selection of potential candidate solutes was realized by an in-silico screening (virtual screening and docking) of 12,055 compounds from Asinex chemotech library. The effect on the free-fraction of indoxyl-sulfate (IS) was tested after an addition of a 1mM solution of octanoic C8 in a solution of bovine serum albumin previously incubated with a solution of IS.


Among the short chain fatty acids tested, C8 and C10 were the more prone to displace dansylsarcosine from site II of albumin (75% for C8 ; displacer/albumin ratio of 5). In silico sreening identify 10 potential candidates among which N-phelyl-glycine and N-phenyl-N-benzenesulfonyl glycine (PBSG) were the best candidates. Indeed, the displacement obtained was roughly 60% for a displacer/albumin ratio between 50 and 250. The addition of a 1mM solution of C8 to a solution of bovine serum albumin permitted an increase of 22% of the free-fraction of IS (p<0.05).


C8 permitted a significant increase in the free fraction of IS in vitro. Nevertheless, significant concentrations of short chain fatty acids can lead to a significant hemolysis. Hence, we identified two interesting solutes that could be interesting to promote the removal of PBT: N-phenyl-glycine and PBSG. Those hydrophilic solutes need to prove their safety under physiological conditions and their effects on other compounds bound onto site II of albumin need further investigations.